Christopher J. Shepherd
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Cells and Metastasis
Papers in
-
- Prostate Cancer Diagnosis and Treatment 2
- Prostate Cancer Treatment and Research 2
- Ferroptosis and cancer prognosis 1
- Renal cell carcinoma treatment 1
- Oncology 5
- Co-authors
- Janet Shipley (2 shared papers)Bingbing Yuan (1 shared paper)Edoardo Missiaglia (1 shared paper)Prakash K. Rao (1 shared paper)Lauren Shields (1 shared paper)Harvey F. Lodish (1 shared paper)David L. Hudson (3 shared papers)Siân Rizzo (3 shared papers)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)The Prostate (1 paper)European Radiology (1 paper)The FASEB Journal (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Christopher J. Shepherd
14 papers receiving 368 citations
Peers
Comparison fields: 5 of 50
- Cancer Research 109
- Oncology 95
- Cell Biology 60
- Pulmonary and Respiratory Medicine 86
- Immunology 44
Countries citing papers authored by Christopher J. Shepherd
This map shows the geographic impact of Christopher J. Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Shepherd more than expected).
Fields of papers citing papers by Christopher J. Shepherd
This network shows the impact of papers produced by Christopher J. Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Shepherd. The network helps show where Christopher J. Shepherd may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher J. Shepherd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 116 | |
| 2 | 2008 | 75 | |
| 3 | 2008 | 48 | |
| 4 | 2023 | 44 | |
| 5 | 2006 | 31 | |
| 6 | 2018 | 26 | |
| 7 | 2006 | 10 | |
| 8 | 2022 | 6 | |
| 9 | 2025 | 3 | |
| 10 | 2009 | 3 | |
| 11 | 2019 | 3 | |
| 12 | 2021 | 3 | |
| 13 | 2017 | 2 | |
| 14 | 2021 | 1 |
About Christopher J. Shepherd
Christopher J. Shepherd is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 14 papers that have together received 371 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Prostate Cancer Treatment and Research (2 papers), Ferroptosis and cancer prognosis (1 paper), Renal cell carcinoma treatment (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Cancer Research (109 citations), Oncology (95 citations), Cell Biology (60 citations), Pulmonary and Respiratory Medicine (86 citations) and Immunology (44 citations). Christopher J. Shepherd has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Janet Shipley, Bingbing Yuan, Edoardo Missiaglia, Prakash K. Rao, Lauren Shields, Harvey F. Lodish, David L. Hudson, Siân Rizzo, Daniel S. Brewer and Melissa Davies. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Prostate, European Radiology and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.